Citigroup provided analyst ratings on Stereotaxis on July 17, 2026.
1 report, 1 independent
Updated Jul 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup provided analyst ratings on Stereotaxis on July 17, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Stereotaxis
American medical robotics company
Related events
- Citigroup reissued a market outperform rating for Applied Digital Corporation on October 15, 2026.
- Citigroup reiterated a market outperform rating for Alphabet Inc.
- Citigroup reiterated a market outperform rating for Capital Southwest Corporation.
- Citigroup restated a buy rating on shares of Intensity Therapeutics.
- Citigroup reiterated a market perform rating for Inhibrx Biosciences.